Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3800159 | 0.90 | TSHR (0.33) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| SCHEMBL2576138 | 0.87 | ALDH1A1 (0.38) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| Acetic Acid SCHEMBL9743919 | 0.84 | TSHR (0.41) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| SCHEMBL677673 | 0.83 | TSHR (0.38) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| Ethylene Glycol SCHEMBL1071330 | 0.83 | TSHR (0.35) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| SCHEMBL166756 | 0.83 | ALDH1A1 (0.38) | PKMALDH1A1 | |
| SCHEMBL173250 | 0.82 | ALDH1A1 (0.54) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| SCHEMBL2189860 | 0.82 | ALDH1A1 (0.48) | TSHRTDP1ALDH1A1 | |
| SCHEMBL8603559 | 0.81 | TSHR (0.38) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 | |
| SCHEMBL173249 | 0.80 | TSHR (0.42) | TSHRTDP1PKMSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200215136-A1 | MEDICATION DISPENSING SYSTEM | WREATH, INC. | 2020-07-09 | — | — | US | claimed |
| US-20240050632-A1 | SELF-EXPANDING DEVICES AND METHODS THEREFOR | INTERSECT ENT, INC | 2024-02-15 | — | — | US | disclosed |
| US-11826494-B2 | Self-expanding devices and methods therefor | INTERSECT ENT, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-20230256100-A1 | MEDICATION SYSTEM | WREATH, INC. | 2023-08-17 | — | — | US | disclosed |
| US-11654216-B2 | Self-expanding devices and methods therefor | INTERSECT ENT, INC. (US) | 2023-05-23 | — | — | US | disclosed |
| US-11564790-B2 | Skin printer | Tran, Bao (US) | 2023-01-31 | — | — | US | disclosed |
| US-11491229-B2 | Medication system | Tran, Bao (US) | 2022-11-08 | — | — | US | disclosed |
| CN-115154424-A | Low-hygroscopicity solid dispersion containing sodium valproate, preparation method of low-hygroscopicity solid dispersion and sustained-release tablet core | 广州茂丰药业有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-109627458-B | Preparation method of quaternary ammonium group-containing (methyl) acrylate copolymer aqueous dispersion | 英德茂丰药业有限公司 | 2021-11-12 | — | — | CN | disclosed |
| US-11110210-B2 | Self-expanding devices and methods therefor | INTERSECT ENT, INC. (US) | 2021-09-07 | — | — | US | disclosed |
| US-20060240065-A1 | Compositions for medical devices containing agent combinations in controlled volumes | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-10-26 | — | — | US | disclosed |
| WO-2006078356-A1 | POLY(HYDROXYALKANOATE-CO-ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| US-20060160985-A1 | POLY(HYDROXYALKANOATE-CO-ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-07-20 | — | — | US | disclosed |
| WO-2006073631-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |
| US-20060147412-A1 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-07-06 | — | — | US | disclosed |
| WO-2006057929-A1 | BIOLOGICALLY ABSORBABLE COATINGS FOR IMPLANTABLE DEVICES BASED ON POLYESTERS AND METHODS FOR FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-06-01 | — | — | WO | disclosed |
| US-20060111546-A1 | Biologically absorbable coatings for implantable devices based on polyesters and methods for fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-05-25 | — | — | US | disclosed |
| WO-2006031398-A2 | COMPOSITIONS CONTAINING FAST-LEACHING PLASTICIZERS FOR IMPROVED PERFORMANCE OF MEDICAL DEVICES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20060058868-A1 | Compositions containing fast-leaching plasticizers for improved performance of medical devices | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-03-16 | — | — | US | disclosed |
| US-20050288481-A1 | Design of poly(ester amides) for the control of agent-release from polymeric compositions | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060147412-A1 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | PUF60, PLOD3, HGF | TSHR 4511/4885TDP1 1328/4885PKM 2127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.